Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model.
Guzman S, Dragan M, Kwon H, de Oliveira V, Rao S, Bhatt V, Kalemba KM, Shah A, Rustgi VK, Wang H, Bech PR, Abbara A, Izzi-Engbeaya C, Manousou P, Guo JY, Guo GL, Radovick S, Dhillo WS, Wondisford FE, Babwah AV, Bhattacharya M.
Guzman S, et al.
J Clin Invest. 2022 May 16;132(10):e145889. doi: 10.1172/JCI145889.
J Clin Invest. 2022.
PMID: 35349482
Free PMC article.